Stage IIIB Breast Cancer Completed Phase 2 Trials for Fulvestrant (DB00947)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00082810Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast CancerTreatment